LY2606368

参考资料仅供科学研究，不可用于个人用途。

货号：BCP14380CAS号：1234015-52-1纯度：98%

在线咨询

购买咨询

全国免运费！免费咨询：400-099-8200 或手机联系：13472751340

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS号	1234015-52-1	货号	BCP14380
关联产品	1234015-55-4（Prexasertib mesylate ） 1234015-54-3（ Prexasertib dihydrochloride） 1234015-57-6（Prexasertib Mesylate Hydrate） 1234015-58-7（Prexasertib dimesylate）
中文名	LY2606368
英文名	LY2606368
中文别名
英文别名	LY 2606368;LY-2606368; Prexasertib;
SMILES
化学名称
分子式	C18H19N7O2	分子量	365.38
纯度	98%	配送	惯例下常温包邮
产品描述	LY2606368 alone significantly inhibited the cell proliferation in a variety of pancreatic cell lines (SW1990, SU86.86, Bx-PC3, AsPC-1, CFPAC-1, Capan-2, HPAF-II) with SW1990 being the most sensitive (IC50=1.5 nM). LY2606368 has been reported to inhibit Chk1 auto-phosphorylation activated by DNA damaging agents, and induce phosphorylation of H2AX, a DNA damage maker in multiple cancer cell lines in vitro. In addition, LY2606368 has demonstrated potent single agent activity and potentiates the anti-tumor activity of DNA damaging agents in vivo. Pancreatic cancer is one of the least curable cancers, with an approximate 5% overall 5-year survival for all patients. In SW1990 pancreas orthotopic model, which represents the local and metastatic growth pattern seen in pancreas cancer patients, LY2606368 treatment resulted in over 92% inhibition of primary tumor growth as well as 100% inhibition of metastasis to lymph node, spleen and intestine. The anti-tumor effect of LY2606368 treatment was